Fintel reports that on April 30, 2025, Leerink Partners downgraded their outlook for Quanterix (NasdaqGM:QTRX) from ...

Fintel reports that on April 30, 2025, Leerink Partners downgraded their outlook for NeoGenomics (NasdaqCM:NEO) from ...

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's drug to treat a type of muscle-weakening ...

Leerink notes that Equillium (EQ) announced that the FDA declined to support an accelerated approval pathway for itolizumab in first-line ...

“This is a clear and deliberate shift,” Corbett says.

Merlin is engaged in lease negotiations to use a former Navy hangar on a nearly 19-acre parcel on the north edge of the ...

Many companies have foreshadowed deals to come during earnings calls in recent days. The return of M&A would be a welcome ...

We recently published a list of The Best and Worst Dow Stocks for the Next 12 Months. In this article, we are going to take a look at where Merck & Co. Inc.

When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and ...

Healthcare stocks have traditionally been seen as a safe haven during market volatility. However, recent developments — particularly President Trump's tariffs and research spending cuts — are changing ...

Penumbra, Inc. (NYSE:PEN – Free Report) – Research analysts at Leerink Partnrs decreased their FY2026 earnings per share estimates for Penumbra in a note issued to investors on Thursday ...